Format

Send to

Choose Destination
See comment in PubMed Commons below
Emerg Infect Dis. 1996 Oct-Dec;2(4):343-9.

Assessing the costs and benefits of an oral vaccine for raccoon rabies: a possible model.

Author information

1
Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Abstract

Any cost-benefit analysis of the use of an oral vaccine to control raccoon rabies should include calculating both costs and benefits in terms of $/unit area. Further, cost savings must be adjusted to match the stages of an epizootic: pre-epizootic, epizootic, and post-epizootic. A generic model, which can be adapted to different sites, illustrates the use of threshold analysis to link distribution costs, cost savings, bait density, and vaccine price. Initial results indicate the need to lower the cost of the vaccine, continue research to determine optimal bait densities, and examine distribution plans that do not require continued protection of areas in which raccoon rabies was eliminated through previous vaccination programs.

PMID:
8969251
PMCID:
PMC2639934
DOI:
10.3201/eid0204.960411
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center